Advanced search
Publication Cover
Journal of Medical Economics Volume 25, 2022 - Issue 1
Submit an article Journal homepage
4,636
Views
8
CrossRef citations to date
0
Altmetric
Oncology

Cost-effectiveness analysis of the Oncotype DX Breast Recurrence Score test in node-positive early breast cancer

Vladislav Berdunova PHMR Ltd, London, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5743-2184View further author information
ORCID Icon,
Steve Millenb Exact Sciences, London, UKView further author information
,
Andrew Paramoreb Exact Sciences, London, UKORCID Iconhttps://orcid.org/0000-0003-4070-9017View further author information
ORCID Icon,
Peter Hallc Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UKORCID Iconhttps://orcid.org/0000-0001-6015-7841View further author information
ORCID Icon,
Timothy Perrend Leeds Teaching Hospitals NHS Trust, Leeds, UKView further author information
,
Rebecca Browna PHMR Ltd, London, UKView further author information
,
Jane Griffine Jane Griffin Associates, East Molesey, UKView further author information
,
Sarah Reyniab Exact Sciences, London, UKView further author information
,
Nina Fryerb Exact Sciences, London, UKView further author information
&
Louise Longwortha PHMR Ltd, London, UKView further author information
 show all
Pages 591-604 | Received 16 Mar 2022, Accepted 12 Apr 2022, Published online: 08 May 2022

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vladislav Berdunov, Ewan Laws, Gebra Cuyun Carter, Roger Luo, Christy Russell, Sara Campbell, Jeremy Force & Yara Abdou. (2023) The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective. Journal of Medical Economics 26:1, pages 973-990.
Read now
Martijn J.H.G. Simons, Peter M. Machielsen, Jelle A. Spoorendonk, Tim Ignacio, Pieter B. Drost, Tim Jacobs & Felix E. deJongh. A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands. Journal of Medical Economics 0:0, pages 1-15.
Read now

Articles from other publishers (6)

Ahmet Necati Sanli, Deniz Esin Tekcan Sanli, Fatih Aydogan & M Kadri Altundag. (2023) Should the Breast Cancer Staging System be Revised?. The American Surgeon™.
Crossref
Charlene Kay, Carlos Martinez-Perez, J. Michael Dixon & Arran K. Turnbull. (2023) The Role of Nodes and Nodal Assessment in Diagnosis, Treatment and Prediction in ER+, Node-Positive Breast Cancer. Journal of Personalized Medicine 13:10, pages 1476.
Crossref
Elsa Curtit, Martine Marie Bellanger, Virginie Nerich, Delphine Hequet, Jean-Sebastien Frenel, Olivier Cristeau & Roman Rouzier. (2023) Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis. Frontiers in Oncology 13.
Crossref
Nathalie LeVasseur & Karen A. Gelmon. (2023) Prognostic Tests in Early-Stage Hormone Receptor–Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care. Journal of Clinical Oncology 41:10, pages 1816-1819.
Crossref
Maria Tsakiroglou, Anthony Evans & Munir Pirmohamed. (2023) Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis. Frontiers in Genetics 14.
Crossref
Diogo Martins-Branco, Sofia Cristóvão Ferreira, Emanuel Gouveia, Saudade André, Susana Esteves, Margarida Brito & António Moreira. (2023) Adjuvant Chemotherapy De-Escalation with Genomic Assay Protocol in Patients with Early Breast Cancer: A Single-Centre Prospective Cohort Study. Acta Médica Portuguesa 36:7-8, pages 487-495.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.